🚀 IS REGENERON PHARMA $REGN A BARGAIN? 🤔

With its stock price at $675.79, let's dive into why some might see it as cheap:

• Oversold status with a score of 70.42% suggests potential buying opportunity.
• Attractive PEG ratio of 0.56 indicates undervaluation against growth expectations.
• Solid growth with a 29.8% rate and a forward P/E of 14.87.

Given its current metrics, does $REGN stand out as a strategic addition to your portfolio? Let's discuss! 📈💡